Fidelity International’s Structure Therapeutics GPCR Stock Holding History

Fidelity International’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,150,440	Closed	-$19.9M	–	990
2025 Q1	$19.9M	Sell	1,150,440 -149,575	-12%	-$3.66M	0.02%	449
2024 Q4	$35.3M	Sell	1,300,015 -10,520	-0.8%	-$373K	0.03%	373
2024 Q3	$57.5M	Buy	1,310,535 +2,567	+0.2%	+$99.3K	0.05%	310
2024 Q2	$51.4M	Buy	1,307,968 +1,251,030	+2,197%	+$51.4M	0.05%	314
2024 Q1	$2.44M	Buy	56,938 +47,634	+512%	+$2.01M	﹤0.01%	668
2023 Q4	$379K	Buy	9,304 +695	+8%	+$39.8K	﹤0.01%	744
2023 Q3	$434K	Buy	+8,609	New	+$277K	﹤0.01%	726

Other funds holding GPCR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity International's GPCR Position: Q2 2025 in Review

Fidelity International sold out of Structure Therapeutics (GPCR) in Q2 2025, closing a stake of 1,150,440 shares — an estimated $19.9M sold.

Fidelity International first reported a position in GPCR in Q3 2023 and held it in 7 quarters. The position peaked at $57.5M in Q3 2024. 172 funds tracked by Wall St. Rank hold GPCR as of Q2 2025.

Fidelity International reported no remaining Structure Therapeutics position as of Q2 2025 after selling out during the quarter.
Fidelity International sold 1,150,440 Structure Therapeutics shares in Q2 2025, an estimated $19.9M.
Fidelity International first reported a position in Structure Therapeutics in Q3 2023 and held it in 7 quarters.
Fidelity International's Structure Therapeutics position peaked at $57.5M in Q3 2024.
172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2025.

Based on Fidelity International's 13F filing for Q2 2025, filed 14 Aug 2025.